John P Amboian
CIK 1188721 · Chief Executive Officer · last filed 2024-07-22
John P Amboian is a Chief Executive Officer who has filed 26 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for DNMR, was dated Jul 22, 2024. Across all open-market trades the lifetime net is −$2.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $436.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
JNC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Danimer Scientific, Inc. (DNMR) Delisted | Director | 9,763 | $0.35 | $3.4K | $0 | 5 | 2024-07-22 |
| Danimer Scientific, Inc. (DNMR.WS) Delisted | Director | — | $11.49 | — | $0 | 2 | 2021-03-25 |
| Nuveen Flexible Investment Income Fund (JPW) Delisted | 10,000 | — | — | $200.0K | 1 | 2013-07-02 | |
| Nuveen Equity Premium Advantage Fund (JLA) Delisted | 5,500 | — | — | $19.2K | 2 | 2010-08-25 | |
| NVG | 4,500 | $11.08 | $49.9K | $274.5K | 3 | 2010-03-05 | |
| NEA | 4,500 | $10.15 | $45.7K | $271.8K | 3 | 2010-03-05 | |
| NUVEEN INVESTMENTS INC (JNC) Delisted | President | 401,183 | — | — | -$3.74M | 4 | 2007-08-07 |
| Nuveen Global Equity Income Fund (JGV) Delisted | 11,000 | — | — | $204.6K | 1 | 2007-08-06 | |
| Nuveen Tax-Advantaged Floating Rate Fund (JFP) Delisted | 15,000 | — | — | $203.1K | 1 | 2007-08-06 | |
| JQC | 16,000 | $4.47 | $71.6K | $196.2K | 1 | 2007-08-06 | |
| JRS | 10,000 | $7.42 | $74.2K | $206.0K | 1 | 2007-08-06 | |
| JCE | 11,500 | $17.00 | $195.5K | $150.1K | 1 | 2007-08-06 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-22 | Danimer Scientific, Inc. (DNMR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-04 | Danimer Scientific, Inc. (DNMR) Delisted | Exer (M) | +26,578 | $0 | EDGAR |
| 2023-06-05 | Danimer Scientific, Inc. (DNMR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-18 | Danimer Scientific, Inc. (DNMR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-10 | Danimer Scientific, Inc. (DNMR) Delisted | Other (J) | +545,915 | $0 | EDGAR |
| 2021-03-25 | Danimer Scientific, Inc. (DNMR.WS) Delisted | Other (J) | — | $0 | EDGAR |
| 2021-01-04 | Danimer Scientific, Inc. (DNMR.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-07-02 | Nuveen Flexible Investment Income Fund (JPW) Delisted | Buy (P) | +10,000 | $200.0K | EDGAR |
| 2010-08-25 | Nuveen Equity Premium Advantage Fund (JLA) Delisted | Sell (S) | −6,185 | -$81.1K | EDGAR |
| 2010-03-05 | NVG | Buy (P) | +4,500 | $45.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.